Basal subtype of head and neck cancer to define response to EGFR inhibitor treatment.

被引：0
|
作者：
Klinghammer, Konrad Friedrich
Otto, Raik
Raguse, Jan D.
Fichtner, Iduna
Albers, Andreas
Keilholz, Ulrich
Hoffmann, Jens
机构：
[1] Charite, Berlin, Germany
[2] Humboldt Univ, Inst Comp Sci, Berlin, Germany
[3] Charite Univ Med Berlin, Clin Oral & Maxillofacial Surg, Berlin, Germany
[4] EPO, Berlin, Germany
[5] Charite, Dept Hematooncol, Ctr Comprehens Canc, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e17512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17512
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Basal subtype is predictive for response to cetuximab treatment in patient- derived xenografts of squamous cell head and neck cancer
    Klinghammer, Konrad
    Otto, Raik
    Raguse, Jan-Dirk
    Albers, Andreas E.
    Tinhofer, Ingeborg
    Fichtner, Iduna
    Leser, Ulf
    Keilholz, Ulrich
    Hoffmann, Jens
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) : 1215 - 1221
  • [2] The incidence of NTRK fusion in Chinese head and neck cancer and response to crizotinib treatment.
    Liu, Lianke
    He, Yuange
    Xu, Jiali
    Wang, Rong
    Chen, Rongrong
    Xia, Xuefeng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Survivorship needs after head and neck cancer treatment.
    Berkowitz, Callie
    Allen, Deborah H.
    Tenhover, Jennifer
    Zullig, Leah L.
    Fischer, Jonathan E.
    Pollak, Kathryn I.
    Hicks, Minoka R.
    Hillson, John V.
    Koontz, Bridget F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Preclinical modeling of EGFR inhibitor resistance in head and neck cancer
    Quesnelle, Kelly M.
    Wheeler, Sarah E.
    Ratay, Mary K.
    Grandis, Jennifer R.
    CANCER BIOLOGY & THERAPY, 2012, 13 (10) : 935 - 945
  • [5] EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines
    Jedlinski, Adam
    Ansell, Anna
    Johansson, Ann-Charlotte
    Roberg, Karin
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013, 42 (01) : 26 - 36
  • [6] Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature
    Rabinowits, Guilherme
    Haddad, Robert I.
    ORAL ONCOLOGY, 2012, 48 (11) : 1085 - 1089
  • [7] Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
    Michmerhuizen, Nicole L.
    Ludwig, Megan L.
    Birkeland, Andrew C.
    Nimmagadda, Sai
    Zhai, Jingyi
    Wang, Jiayu
    Jewell, Brittany M.
    Genouw, Dylan
    Remer, Lindsay
    Kim, Daniel
    Foltin, Susan K.
    Bhangale, Apurva
    Kulkarni, Aditi
    Bradford, Carol R.
    Swiecicki, Paul L.
    Carey, Thomas E.
    Jiang, Hui
    Brenner, J. Chad
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (05): : 1192 - 1205
  • [8] Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: Implications for anti-EGFR treatment response
    Boeckx C.
    Weyn C.
    Vanden Bempt I.
    Deschoolmeester V.
    Wouters A.
    Specenier P.
    Van Laer C.
    Van Den Weyngaert D.
    Kockx M.
    Vermorken J.B.
    Peeters M.
    Pauwels P.
    Lardon F.
    Baay M.
    BMC Research Notes, 7 (1)
  • [9] Chemoradiotherapy in head and neck cancer: an option for radical treatment. Our experience
    Navarro Bergada, A. V.
    Lorca Chapa, J.
    Saiz Monfort, V.
    Bermell Carrion, A.
    Pastor Del Campo, A.
    Jornet Fayos, J.
    Barrios, G.
    Tarazona, F.
    Albert Antequera, M.
    Domingo Boluda, C.
    Lopez Munoz, M.
    Monroy Anton, J.
    Soler Rodriguez, A.
    Soler Tortosa, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S640 - S640
  • [10] INFORMATION TO PATIENTS WITH HEAD AND NECK CANCER DURING THE PERIOD OF RADIATION TREATMENT.
    Egestad, H.
    Hanssen, S.
    Tunstad, J. H.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S524 - S524
12345